Clinical Trial Update: A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG) [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluated the potential benefit of adding hydroxychloroquine to short-course radiotherapy in patients aged 70 and older with high-gra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University College, London | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED